Form 8-K - Current report:
SEC Accession No. 0001437749-23-016926
Filing Date
2023-06-08
Accepted
2023-06-08 07:00:36
Documents
14
Period of Report
2023-06-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20230607_8k.htm   iXBRL 8-K 26786
2 EXHIBIT 99.1 ex_531095.htm EX-99.1 11408
  Complete submission text file 0001437749-23-016926.txt   190432

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230608.xsd EX-101.SCH 4058
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230608_def.xml EX-101.DEF 13541
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230608_lab.xml EX-101.LAB 17731
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230608_pre.xml EX-101.PRE 13508
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230607_8k_htm.xml XML 4331
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 231000672
SIC: 2836 Biological Products, (No Diagnostic Substances)